Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 75,274.87 million compared to CNY 70,550.19 million a year ago. Net income was CNY 4,055.68 million compared to CNY 3,966.52 million a year ago.

Basic earnings per share from continuing operations was CNY 2.495 compared to CNY 2.44 a year ago. Diluted earnings per share from continuing operations was CNY 2.495 compared to CNY 2.44 a year ago.